Systematic analysis of design and stratification for phase III trials in first‐line advanced non‐small cell lung cancer

por Komiya, Takefumi, Perez, Raymond P., Erickson, Kirsten D., Huang, Chao H.
Publicado 2015

Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Pro...

por Perez, Raymond P, Finnigan, Shanda, Patel, Krupa, Whitney, Shanell, Forrest, Annemarie
Publicado 2016

Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studies

por Perez, Raymond P., Chen, Eric, Thaddeus Beck, J., Shirai, Keisuke, Neil Hayes, David, Shen, Tong, Baldwin, John R., Bryant, Katherine B., He, Shuang, Chin, Steve
Publicado 2019

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the F...

por Martin, Lainie P., Konner, Jason A., Moore, Kathleen N., Seward, Shelly M., Matulonis, Ursula A., Perez, Raymond P., Su, Ying, Berkenblit, Anna, Ruiz-Soto, Rodrigo, Birrer, Michael J.
Publicado 2017

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

por Goldstein, Lori J., Perez, Raymond P., Yardley, Denise, Han, Linda K., Reuben, James M., Gao, Hui, McCanna, Susan, Butler, Beth, Ruffini, Pier Adelchi, Liu, Yi, Rosato, Roberto R., Chang, Jenny C.
Publicado 2020

Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

por Goldstein, Lori J., Perez, Raymond P., Yardley, Denise, Han, Linda K., Reuben, James M., Gao, Hui, McCanna, Susan, Butler, Beth, Ruffini, Pier Adelchi, Liu, Yi, Rosato, Roberto R., Chang, Jenny C.
Publicado 2020